和黄医药(00013)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00013 和黄医药

已收盘 12-17 16:08:10

20.540

+0.240

+1.18%

最高20.580	最低20.200	成交量291.90万
今开20.400	昨收20.300	日振幅1.87%
总市值179.11亿	流通市值179.11亿	总股本8.72亿
成交额5,978万	换手率0.33%	流通股本8.72亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00013","market":"HK","secType":"STK","nameCN":"和黄医药","latestPrice":20.54,"timestamp":1765958890003,"preClose":20.3,"halted":0,"volume":2919020,"delay":0,"floatShares":872000000,"shares":872000000,"eps":0.3431699005710551,"marketStatus":"已收盘","change":0.24,"latestTime":"12-17 16:08:10","open":20.4,"high":20.58,"low":20.2,"amount":59784500,"amplitude":0.018719,"askPrice":20.54,"askSize":27500,"bidPrice":20.5,"bidSize":5500,"shortable":3,"etf":0,"ttmEps":4.12220112966219,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"listingDate":1624982400000,"exchange":"SEHK","adjPreClose":20.3,"openAndCloseTimeList":[[1765935000000,1765944000000],[1765947600000,1765958400000]],"volumeRatio":0.474571,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00013/tweets","defaultTab":"tweets","newsList":[{"id":"2592956602","title":"和黄医药(00013)启动ATTC候选药物HMPL-A251用于治疗实体瘤的全球临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2592956602","media":"智通财经","labels":["productRelease"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592956602?lang=zh_cn&edition=full","pubTime":"2025-12-17 08:15","pubTimestamp":1765930513,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和黄医药 发布公告，启动HMPL-A251的全球I期临床开发项目。这项首个人体试验是一项 I/IIa 期、开放标签、多中心临床研究，旨在评估HMPL-A251单药用于治疗不可切除、伴有HER2 表达的晚期或转移性实体瘤成人患者。次要指标包括初步抗肿瘤活性、药代动力学特征以及HMPL-A251的免疫原性。HMPL-A251是和黄医药新一代ATTC平台旗下首个进入临床开发阶段的候选药物。HMPL-A251 的临床前数据已于2025年AACR-NCI-EORTC分子靶向和癌症治疗国际会议上公布。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和黄医药(00013)启动ATTC候选药物HMPL-A251用于治疗实体瘤的全球临床开发","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00013","BK1587","BK4531","BK1588","BK4585","HCM","BK4007","BK4588","BK1191"],"gpt_icon":0},{"id":"1162114850","title":"和黄医药启动HMPL-A251抗癌候选药物在实体肿瘤患者中的全球临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1162114850","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162114850?lang=zh_cn&edition=full","pubTime":"2025-12-17 08:05","pubTimestamp":1765929948,"startTime":"0","endTime":"0","summary":"和黄医药启动HMPL-A251抗癌候选药物在实体肿瘤患者中的全球临床开发","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","BK1191","BK1587","00013"],"gpt_icon":0},{"id":"2591987214","title":"每日卖空追踪 | 和黄医药 12月16日卖空量成交24.5万股，卖空比例为3.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591987214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591987214?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873808,"startTime":"0","endTime":"0","summary":"和黄医药北京时间12月16日，跌2.5%，卖空量成交24.5万股，较上一交易日减少43.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163035a4519a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163035a4519a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","BK1191","BK1587","00013"],"gpt_icon":0},{"id":"2591987736","title":"和黄医药12月16日遭主力抛售175.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591987736","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591987736?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:15","pubTimestamp":1765872958,"startTime":"0","endTime":"0","summary":"12月16日, 和黄医药股价跌2.50%，报收20.30元，成交金额1.4亿元，换手率0.81%，振幅4.18%，量比1.19。和黄医药今日主力资金净流出175.3万元，上一交易日主力净流出1492.6万元。该股近5个交易日下跌5.91%，主力资金累计净流入876.0万元；近20日主力资金累计净流入1022.1万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162232a6a8a876&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162232a6a8a876&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1588","BK1587","00013"],"gpt_icon":0},{"id":"2591863319","title":"和黄医药12月12日获主力加仓1079.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591863319","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591863319?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:15","pubTimestamp":1765527340,"startTime":"0","endTime":"0","summary":"12月12日, 和黄医药股价涨1.99%，报收21.48元，成交金额1.5亿元，换手率0.78%，振幅2.56%，量比1.40。和黄医药今日主力资金净流入1079.5万元，连续3日净流入，上一交易日主力净流入745.9万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为47.06%，平均涨幅为3.27%。该股近5个交易日上涨1.55%，主力资金累计净流入1701.2万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1127.6万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212162346a4445b69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212162346a4445b69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","00013","BK1191","BK1588"],"gpt_icon":0},{"id":"2590540944","title":"每日卖空追踪 | 和黄医药 12月11日卖空量成交22.65万股，卖空比例为3.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590540944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590540944?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:30","pubTimestamp":1765441808,"startTime":"0","endTime":"0","summary":"和黄医药北京时间12月11日，跌1.68%，卖空量成交22.65万股，较上一交易日减少77.73%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211163112979c661c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211163112979c661c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1191","BK1588","00013"],"gpt_icon":0},{"id":"2590561563","title":"和黄医药“赛沃替尼”胃癌适应症拟优先审批","url":"https://stock-news.laohu8.com/highlight/detail?id=2590561563","media":"医药魔方Info","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590561563?lang=zh_cn&edition=full","pubTime":"2025-12-10 18:25","pubTimestamp":1765362318,"startTime":"0","endTime":"0","summary":"12月10日，CDE官网显示，和黄医药的赛沃替尼新适应症拟优先审批，用于治疗经过至少2种系统化疗失败的MET基因扩增的局部晚期或转移性胃癌或胃食道连接部腺癌成人患者。2011年12月，阿斯利康与和黄医药达成合作协议，前者主导赛沃替尼在中国的开发工作，阿斯利康则主导海外开发工作。此外，和黄医药负责赛沃替尼在中国的上市许可、生产和供应，而阿斯利康则负责实现赛沃替尼在中国乃至全球范围内的商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211015742a44092b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211015742a44092b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00013","BK1587","BK1588","BK1191"],"gpt_icon":0},{"id":"2590314862","title":"每日卖空追踪 | 和黄医药 12月09日卖空量成交68.1万股，卖空比例为11.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590314862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590314862?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:30","pubTimestamp":1765269008,"startTime":"0","endTime":"0","summary":"和黄医药北京时间12月09日，跌1.37%，卖空量成交68.1万股，较上一交易日增加206.07%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209163041953319f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209163041953319f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1588","00013","BK1587"],"gpt_icon":0},{"id":"2589351925","title":"每日卖空追踪 | 和黄医药 12月08日卖空量成交7.75万股，卖空比例为2.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589351925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589351925?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182607,"startTime":"0","endTime":"0","summary":"和黄医药北京时间12月08日，跌0.18%，卖空量成交7.75万股，较上一交易日减少87.22%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081630339531071b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081630339531071b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00013","BK1587","BK1588","BK1191"],"gpt_icon":0},{"id":"2589351997","title":"和黄医药12月08日遭主力抛售144.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589351997","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589351997?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181750,"startTime":"0","endTime":"0","summary":"12月08日, 和黄医药股价跌0.18%，报收21.96元，成交金额8242.3万元，换手率0.43%，振幅2.18%，量比1.07。和黄医药今日主力资金净流出144.5万元，上一交易日主力净流出567.0万元。该股近5个交易日下跌3.26%，主力资金累计净流出1214.8万元；近20日主力资金累计净流入1465.6万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816202895310129&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816202895310129&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1191","BK1588","00013"],"gpt_icon":0},{"id":"2589804367","title":"和黄医药(00013)：达唯珂®(TAZVERIK®)获纳入首版国家商业健康保险创新药品目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589804367","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589804367?lang=zh_cn&edition=full","pubTime":"2025-12-08 08:13","pubTimestamp":1765152816,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和黄医药(00013)发布公告，经过与中国国家医疗保障局(国家医保局)的医保续约，爱优特®(ELUNATE®)、沃瑞沙®(ORPATHYS®)和苏泰达®(SULANDA®)将继续获纳入自2026年1月1日起生效的新版《国家基本医疗保险、工伤保险和生育保险药品目录》(国家医保药品目录)。此外，达唯珂®(TAZVERIK®)获纳入首版国家商业健康保险创新药品目录(简称商保创新药目录)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","HCM","BK4588","BK4007","BK4531","BK1588","00013","BK4585","BK1191"],"gpt_icon":0},{"id":"1142873254","title":"和黄医药宣布在中国扩大药品报销范围并纳入首个商业保险药品列表","url":"https://stock-news.laohu8.com/highlight/detail?id=1142873254","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142873254?lang=zh_cn&edition=full","pubTime":"2025-12-08 08:04","pubTimestamp":1765152250,"startTime":"0","endTime":"0","summary":"和黄医药宣布在中国扩大药品报销范围并纳入首个商业保险药品列表","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","00013","BK1191","BK1587"],"gpt_icon":0},{"id":"2589183896","title":"和黄医药12月05日主力净流出567.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2589183896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589183896?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:15","pubTimestamp":1764922536,"startTime":"0","endTime":"0","summary":"12月05日, 和黄医药股价跌1.08%，报收22.00元，成交金额8472.8万元，换手率0.44%，振幅2.25%，量比1.22。和黄医药今日主力资金净流出567.0万元，上一交易日主力净流入606.0万元。该股近5个交易日下跌2.14%，主力资金累计净流出703.6万元；近20日主力资金累计净流入833.2万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161834a4ce5cfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161834a4ce5cfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","00013","BK1191","BK1588"],"gpt_icon":0},{"id":"2589589618","title":"“华润系”又卖掉一家药企！医药行业企业集体“减负”","url":"https://stock-news.laohu8.com/highlight/detail?id=2589589618","media":"中国制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589589618?lang=zh_cn&edition=full","pubTime":"2025-12-05 14:04","pubTimestamp":1764914687,"startTime":"0","endTime":"0","summary":"至此， 金种子酒 不再持有金太阳药业股权，金太阳药业不再纳入其合并报表范围。今年以来，“华润系”频繁出售非核心资产。一场“减负”潮席卷医药行业。业内表示，这场行业“减负”潮，本质上是医药行业的一次自我优化与升级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205140900a7253e36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205140900a7253e36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","01109","00013","BK1587","02359","BK1588","BK1191"],"gpt_icon":0},{"id":"2589961818","title":"和黄医药第三代 BTK 抑制剂启动首个 Ⅲ 期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2589961818","media":"丁香园 Insight 数据库","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589961818?lang=zh_cn&edition=full","pubTime":"2025-12-05 12:04","pubTimestamp":1764907444,"startTime":"0","endTime":"0","summary":"BTK 被认为是旨在治疗若干血液癌症的药物的有效靶点，然而 BTK 的 C481S 突变是第一代及第二代 BTK 抑制剂的已知耐药机理。HMPL-760 是一种新型、非共价的第三代 BTK 抑制剂。临床前研究显示，作为一种选择性和可逆性的 BTK 抑制剂，HMPL-760 可同时靶向野生型 BTK 和 C481S 突变型 BTK，旨在克服患者对初代 BTK 抑制剂的耐药性。在 8 名接受 BTKi 治疗的患者中，ORR 为 87.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205132427a4ce0c6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205132427a4ce0c6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1191","00013","BK1588"],"gpt_icon":0},{"id":"2589852755","title":"交银国际：中国医药1-8批国采接续规则或温和 短期催化剂充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2589852755","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589852755?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:18","pubTimestamp":1764901122,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，本周恒生医疗保健指数涨0.5%，跑输大市。其中，生物药、处方药及器械板块表现较优于其他板块。本周内资偏向防御，倾向获利了结，主要加仓内生增长稳定的传统及低估创新药厂。而外资则较积极，聚焦创新主线中的龙头及产业链上游，包括创新药及CXO标的。1-8批集采接续采购规则转变为询价模式，交银国际认为此规则下整体降价幅度或有限，对港股处方药厂的影响或小于预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096","00013","BK1588","03329","BK1191","HK0000165453.HKD","LU2488822045.USD","BK0028","BK0082","BK1147","600056","SG9999014674.SGD","BK0185","BK1161","BK1583","BK0188","BK1593","02268","01530","BK0175","06996","BK0250","BK1587","BK0010","BK1574","BK1141"],"gpt_icon":0},{"id":"2589834852","title":"每日卖空追踪 | 和黄医药 12月04日卖空量成交14.4万股，卖空比例为4.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589834852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589834852?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837008,"startTime":"0","endTime":"0","summary":"和黄医药北京时间12月04日，涨0.63%，卖空量成交14.4万股，较上一交易日减少87.11%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163025a4cc357e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163025a4cc357e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","BK1191","BK1587","00013"],"gpt_icon":0},{"id":"2588398070","title":"和黄医药12月03日遭主力抛售556.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588398070","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588398070?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749758,"startTime":"0","endTime":"0","summary":"12月03日, 和黄医药股价跌1.69%，报收22.10元，成交金额9396.6万元，换手率0.49%，振幅3.38%，量比1.37。和黄医药今日主力资金净流出556.7万元，上一交易日主力净流出552.6万元。该股近5个交易日下跌1.34%，主力资金累计净流入330.1万元；近20日主力资金累计净流入462.5万元，其中净流入天数为12日。该股主力净额占比0.03%，港股市场排名2506/2682。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162139a4c9e717&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162139a4c9e717&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1588","BK1587","00013"],"gpt_icon":0},{"id":"2588051575","title":"每日卖空追踪 | 和黄医药 12月02日卖空量成交18.6万股，卖空比例为6.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588051575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588051575?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:30","pubTimestamp":1764664207,"startTime":"0","endTime":"0","summary":"和黄医药北京时间12月02日，跌0.88%，卖空量成交18.6万股，较上一交易日减少61.57%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163012a4c79cc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163012a4c79cc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1587","00013","BK1588"],"gpt_icon":0},{"id":"2588405157","title":"和黄医药12月02日主力净流出552.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588405157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588405157?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:15","pubTimestamp":1764663340,"startTime":"0","endTime":"0","summary":"12月02日, 和黄医药股价跌0.88%，报收22.48元，成交金额6146.3万元，换手率0.31%，振幅2.03%，量比0.87。和黄医药今日主力资金净流出552.6万元，上一交易日主力净流入366.7万元。该股近5个交易日上涨1.08%，主力资金累计净流入921.9万元；近20日主力资金累计净流入1336.8万元，其中净流入天数为13日。该股主力净额占比0.03%，港股市场排名2528/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202161855a71eb53c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202161855a71eb53c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00013","BK1191","BK1588","BK1587"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hutch-med.com","stockEarnings":[{"period":"1week","weight":-0.0628},{"period":"1month","weight":-0.1463},{"period":"3month","weight":-0.2645},{"period":"6month","weight":-0.1453},{"period":"1year","weight":-0.1343},{"period":"ytd","weight":-0.0998}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.0679},{"period":"3month","weight":-0.0622},{"period":"6month","weight":0.086},{"period":"1year","weight":0.2748},{"period":"ytd","weight":0.258}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和黄医药（中国）有限公司是一间主要从事制造及销售药物的投资控股公司。该公司主要通过两个分部运营业务。肿瘤免疫业务分部从事发现、开发和商业化用于治疗癌症和免疫性疾病的靶向疗法和免疫疗法。其中研发包括涵盖药物发现、开发、生产及监管职能的研发活动，上市产品包括通过研发活动开发的药物的已开具发票的销售、推广、生产及分销。其他业务分部从事其他商业化业务，包括其他处方药物及保健品的销售、推广、生产及分销。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.116447},{"month":2,"riseRate":0.75,"avgChangeRate":0.102065},{"month":3,"riseRate":0.25,"avgChangeRate":-0.11719},{"month":4,"riseRate":0.5,"avgChangeRate":0.030514},{"month":5,"riseRate":0,"avgChangeRate":-0.153959},{"month":6,"riseRate":0.5,"avgChangeRate":0.026468},{"month":7,"riseRate":1,"avgChangeRate":0.148281},{"month":8,"riseRate":0.2,"avgChangeRate":-0.0763},{"month":9,"riseRate":0.6,"avgChangeRate":-0.004654},{"month":10,"riseRate":0.2,"avgChangeRate":-0.040611},{"month":11,"riseRate":0.4,"avgChangeRate":0.13917},{"month":12,"riseRate":0.4,"avgChangeRate":-0.032864}],"exchange":"SEHK","name":"和黄医药","nameEN":"HUTCHMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和黄医药(00013)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和黄医药(00013)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和黄医药,00013,和黄医药股票,和黄医药股票老虎,和黄医药股票老虎国际,和黄医药行情,和黄医药股票行情,和黄医药股价,和黄医药股市,和黄医药股票价格,和黄医药股票交易,和黄医药股票购买,和黄医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和黄医药(00013)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和黄医药(00013)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}